ESR1 and breast carcinoma: In order to determine the function of miR-29a in breast cancer, we firstly knocked down miR-29a in two ERα- cell lines MDA-MB-231 and MCF-10A-Src (MCF-10A cells transformed by v-Src, Supplemental Fig. S1), followed by cellular function assays.